BioReference Laboratories
The recently launched digital health service allows patients to schedule sample collection for laboratory tests at their homes or offices.
While increased POC and home testing could cut into the conventional lab business, it also fits with existing industry trends toward more patient-centered models.
In Brief This Week: PerkinElmer, Qiagen, BioReference Laboratories, AstraZeneca, and More
News items for the in vitro diagnostics industry for the week of April 26, 2021.
Increased competition from point-of-care and home tests and the rollout of vaccines appear to be cutting into demand for lab-based molecular SARS-CoV-2 assays.
Opko Health Q1 Revenues More Than Double Due to COVID-19 Test Demand
The company reported revenues of $545.2 million compared to $211.5 million in the year-ago quarter, primarily driven by COVID-19 testing.